Order Article Reprints

Dai WF, de Oliveira C, Blommaert S, Pataky RE, Tran D, Aurangzeb Z, Kendell C, Folkins C, Somayaji C, Dowden J, et al. Mapping Canadian Data Assets to Generate Real-World Evidence: Lessons Learned from Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration’s RWE Data Working Group. Current Oncology. 2022; 29(3):2046-2063. https://doi.org/10.3390/curroncol29030165

Dai, Wei Fang, Claire de Oliveira, Scott Blommaert, Reka E. Pataky, David Tran, Zeb Aurangzeb, Cynthia Kendell, Chris Folkins, Chandy Somayaji, Jeff Dowden, and et al. 2022. "Mapping Canadian Data Assets to Generate Real-World Evidence: Lessons Learned from Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration’s RWE Data Working Group" Current Oncology 29, no. 3: 2046-2063. https://doi.org/10.3390/curroncol29030165

Dai, W. F., de Oliveira, C., Blommaert, S., Pataky, R. E., Tran, D., Aurangzeb, Z., Kendell, C., Folkins, C., Somayaji, C., Dowden, J., Cheung, W., Strumpf, E., Beca, J. M., McClure, C., Urquhart, R., McDonald, J. T., Alvi, R., Turner, D., Peacock, S., ... on behalf of the CanREValue Collaboration. (2022). Mapping Canadian Data Assets to Generate Real-World Evidence: Lessons Learned from Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration’s RWE Data Working Group. Current Oncology, 29(3), 2046-2063. https://doi.org/10.3390/curroncol29030165